BURLINGTON, Mass., May 13, 2024
/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the
grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of
GENEWIZ Multiomics & Synthesis Solutions further in the UK
market. The new laboratory brings Azenta closer to UK-based
researchers, providing advanced next-generation sequencing (NGS)
platforms and a local team of top-tier scientists from Oxford.
"We're thrilled to open our Oxford laboratory, which allows us to bring
state-of-the-art NGS technology to UK researchers," said Dr
Ginger Zhou, President of Azenta's
Multiomics business unit. "This new facility not only
strengthens our global footprint but also offers researchers access
to local experts and cutting-edge resources. The Oxford team comprises some of the best minds
in the field, all with deep roots in the local scientific
community."
The opening event, held on April 25,
2024, featured a ribbon-cutting ceremony, a lab tour, and a
celebratory reception with key stakeholders, including members of
the local scientific community, distinguished guests, and Azenta
executives.
Dr David Buck, Director of Lab
Services Oxford added, "This new lab represents our commitment to
supporting UK researchers by delivering high-quality data faster,
advancing research and development in critical fields such as
diabetes, infectious diseases, Alzheimer's and more. We're excited
about the energy, engagement, and collaboration with the scientific
community, and we look forward to contributing to their
success."
"Having an amazing genomics facility like the one Azenta has
opened at our doorstep, allows us to work faster, achieving more in
less time, with higher accuracy and for an effective cost.
This helps us enhance discovery in medical research to
patient benefit." Said Dr. John
Todd, Professor of Precision Medicine at the University of Oxford, who attended the opening
event.
The Oxford Genomics Laboratory was created with customer
convenience in mind. It offers a network of GENEWIZ
collection points plus free-of-charge, same day dry ice sample
collection in Oxford, and
Cambridge, streamlining the sample
submission process for researchers. The lab provides a
comprehensive suite of NGS services; library preparation,
sequencing, bioinformatics analysis with UK based data storage,
plus soon to be, a range of DNA/RNA extraction capabilities, all
backed by experienced Ph.D.-level study managers who guide projects
from conception to delivery.
GENEWIZ from Azenta is equipped with the latest, cutting-edge
NGS platforms globally to enable service users to stay at the
forefront of scientific innovation. Some of these platforms
include: Illumina NovaSeq™ X Plus, PacBio Revio, Oxford
Nanopore Technologies GridION, PromethION 2 Solo, 10x Genomics
Chromium X, Nanostring GeoMx® &
nCounter®, and Olink® Protein Biomarker
Detection.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA)
is a leading provider of life sciences solutions worldwide,
enabling impactful breakthroughs and therapies to market faster.
Azenta provides a full suite of reliable cold-chain sample
management solutions and multiomics services across areas such as
drug development, clinical research and advanced cell therapies for
the industry's top pharmaceutical, biotech, academic and healthcare
institutions globally. Our global team delivers and supports these
products and services through our industry-leading brands,
including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro,
Barkey and B Medical Systems.
Azenta is headquartered in Burlington, MA, with operations
in North America, Europe and Asia. For
more information, please visit www.azenta.com.
INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial Planning & Analysis, and Investor
Relations
ir@azenta.com
Sherry Dinsmore
sherry.dinsmore@azenta.com
Azenta's use of third-party trademarks and brands are for
identification only and does not imply affiliation or
endorsement. All trademarks used herein are the property of
their respective owners.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/azenta-opens-the-doors-to-its-new-genomics-laboratory-in-oxford-uk-302143963.html
SOURCE Azenta